Journal list menu
Export Citations
Download PDFs
ISSUE INFORMATION
ORIGINAL ARTICLES
Open Access
oa
Effect of eculizumab treatment in patients with paroxysmal nocturnal hemoglobinuria with or without high disease activity: Real-world findings from the International Paroxysmal Nocturnal Hemoglobinuria Registry
- Pages: 197-204
- First Published: 07 April 2022
Open Access
oa
Long-term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2-year results from two pivotal phase 3 studies
- Pages: 205-214
- First Published: 03 May 2022
Open Access
oa
Development and validation of the sickle cell stress scale-adult
- Pages: 215-225
- First Published: 18 May 2022
Open Access
oa
Validation of patient-reported vaso-occlusive crisis day as an endpoint in sickle cell disease studies
- Pages: 226-237
- First Published: 15 May 2022
no
Incidence of adult primary immune thrombocytopenia in England—An update
- Pages: 238-249
- First Published: 07 June 2022
no
Autologous stem cell transplantation in multiple myeloma patients over 70 years: A GIMEMA Lazio Working Group experience in a retrospective case–control study
- Pages: 250-256
- First Published: 26 May 2022
no
Efficacy of conventional-dose cytarabine, idarubicin and thioguanine versus intermediate-dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long-term results of the prospective randomized nationwide AML-2003 study by the Finnish Leukemia Group
- Pages: 257-270
- First Published: 30 May 2022
no
Cell-free DNA levels are increased in acute graft-versus-host disease
- Pages: 271-281
- First Published: 26 May 2022
no
Venous thromboembolism prophylaxis in hospitalized sickle cell disease and sickle cell trait patients
- Pages: 282-288
- First Published: 26 May 2022
no
Relationship between pancreatic iron overload, glucose metabolism and cardiac complications in sickle cell disease: An Italian multicentre study
- Pages: 289-297
- First Published: 11 June 2022
no
Herpes zoster prophylaxis with low-dose acyclovir in patients with malignant lymphoma and multiple myeloma treated with autologous stem cell transplantation
- Pages: 298-304
- First Published: 10 June 2022
LETTER TO THE EDITOR
no
Generic Lenalidomide: An opportunity to address the balance of administrative burden and drug safety
- Pages: 305-306
- First Published: 27 May 2022